Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Small Volume Parenteral Market From 2025 To 2029?
The market size for small volume parenteral has seen substantial growth in recent times. Its worth is expected to rise from $177.26 billion in 2024 to $191.36 billion in 2025, posting a compound annual growth rate (CAGR) of 8.0%. The increment in this period was driven by factors such as the increasing occurrence of chronic diseases, official permissions and government-led initiatives, pharmaceutical outsourcing shifts, and the globalization and enlargement of pharmaceutical markets.
It is anticipated that the small volume parenteral market will experience substantial growth in the coming years, with its size projected to reach $258.88 billion by 2029, expanding at a compound annual growth rate (CAGR) of 7.8%. Factors attributing to this predicted growth during the forecast period include the burgeoning biologics market, the development of healthcare infrastructure, elevated rates of hospitalization, regulatory greenlights, the shift towards home healthcare, escalated investments in healthcare, and various global health epidemics. Key trends during the projected period cover the growth in biocompatible formulations, a focus on patient-centric strategies, the rise of home healthcare, innovative advancements in manufacturing automation, broader therapeutic area expansion, and the emergence of intelligent pump technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp
Which Primay Drivers Are Accelerating Growth in the Small Volume Parenteral Market?
Growth in the small-volume parenteral market is predicted to be spurred by the rise in the number of surgeries. Surgical procedures represent a medical field that relies on operative methodologies to examine or address pathological conditions like disease or injury, enhance physical functions or appearance, or mend unwanted ruptured areas. The frequency of surgical procedures is escalating due to progress in medical technology and an aging demographic, thereby sparking a higher need for surgical interventions. Small-volume parenteral solutions are harnessed during surgeries for the accurate administration of medications, electrolytes, and nutrients straight into the bloodstream. For example, data from The Aesthetic Society, a US organization focused on plastic surgery and cosmetic medicine, reveals that in August 2023, Americans shelled out more than $11.8 billion on aesthetic procedures in total, marking a 2% rise from the previous year. Consequently, the upswing in surgical procedures is fueling the expansion of the small-volume parenteral market.
Which Primary Segments of the Small Volume Parenteral Market Are Driving Growth and Industry Transformations?
The small volume parenteralmarket covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15925&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Small Volume Parenteral Market?# Market?
North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Technological Trends Are Reshaping the Small Volume Parenteral Industry Dynamics?
Leading corporations in the small volume parenteral market are turning their attention towards the creation of inventive solutions such as the integrated lyophilizer, to escalate profits. The in-built lyophilizer is a combined system in the production line that converts products into freeze-dried powders, typically used for particular parenteral drugs. An example of this innovation is seen in January 2022 when WuXi STA, a pharmaceutical firm based in China, introduced a production line for parenteral formulation. The freshly constructed formulation production line, coupled with the sterile manufacturing facility in Wuxi, conforms to the cGMP norms imposed by the U.S. FDA, EMA, and China NMPA. It incorporates the most modern isolation systems and filler machines in the sector. The whole filling operation is accomplished via robotics in a completely secluded setting. This set-up is intended to reduce human involvement and avoid pollution, thus guaranteeing superior product quality.
View the full report here:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
What Parameters Are Used to Define the Small Volume Parenteral Market?
Small volume parenteral (SVP) refers to a category of sterile drug products that are intended for parenteral administration (bypassing the gastrointestinal tract) and are typically provided in volumes of 100 milliliters (mL) or less. These products are used for various medical purposes, including delivering medications, vaccines, or biological treatments directly into the body via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15925
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
